Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends extension of Ozurdex indication in diabetic macular edema

July 28, 2014

EMA committee recommends approval of Zydelig in CLL and follicular lymphoma

July 28, 2014

CHMP adopts positive opinion for Imbruvica in CLL and MCL

July 28, 2014

First vaccine candidate for malaria accepted for E.U. regulatory review

July 25, 2014

EMA accepts MAA for asfotase alfa as a treatment for hypophosphatasia

July 25, 2014

Sunesis Pharmaceuticals receives positive opinion on pediatric investigation plan for vosaroxin

July 10, 2014

Teva Pharmaceutical receives positive CHMP opinion for Seasonique

July 7, 2014

EMA accepts for review Merck & Co.'s MAA for anti-PD-1 MAb pembrolizumab

July 1, 2014

CHMP recommends Velphoro for control of serum phosphorus levels in adults with CKD

July 1, 2014

EMA committee recommends approval of Triumeq

July 1, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...